↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID21948594.edit
↑Smith, WW; Sancilio, LF; Owera-Atepo, JB; Naylor, RJ; Lambert, L (1988). „Zacopride, a potent 5-HT3 antagonist”. The Journal of pharmacy and pharmacology40 (4): 301–2. DOI:10.1111/j.2042-7158.1988.tb05253.x. PMID2900319.
↑Lefebvre, H; Contesse, V; Delarue, C; Soubrane, C; Legrand, A; Kuhn, JM; Wolf, LM; Vaudry, H (1993). „Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies”. The Journal of Clinical Endocrinology and Metabolism77 (6): 1662–6. DOI:10.1210/jc.77.6.1662. PMID8263156.
↑Young, R; Johnson, DN (1991). „Anxiolytic-like activity of R(+)- and S(-)-zacopride in mice”. European Journal of Pharmacology201 (2–3): 151–5. DOI:10.1016/0014-2999(91)90338-Q. PMID1686755.
↑Costall, B; Domeney, AM; Gerrard, PA; Kelly, ME; Naylor, RJ (1988). „Zacopride: anxiolytic profile in rodent and primate models of anxiety”. The Journal of pharmacy and pharmacology40 (4): 302–5. DOI:10.1111/j.2042-7158.1988.tb05254.x. PMID2900320.
↑Yamakuni, H; Nakayama, H; Matsui, S; Imazumi, K; Matsuo, M; Mutoh, S (2006). „Inhibitory effect of zacopride on Cisplatin-induced delayed emesis in ferrets”. Journal of pharmacological sciences101 (1): 99–102. DOI:10.1254/jphs.SCJ05007X. PMID16651699.
↑Carley, DW; Depoortere, H; Radulovacki, M (2001). „R-zacopride, a 5-HT3 antagonist/5-HT4 agonist, reduces sleep apneas in rats”. Pharmacology, Biochemistry, and Behavior69 (1–2): 283–9. DOI:10.1016/S0091-3057(01)00535-4. PMID11420096.
↑Meyer, LC; Fuller, A; Mitchell, D (2006). „Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats”. American journal of physiology. Regulatory, integrative and comparative physiology290 (2): R405–13. DOI:10.1152/ajpregu.00440.2005. PMID16166206.